- Controlled IL-12 advancing as drug platform as monotherapy and in combination with OPDIVO® ...
Dublin, June 13, 2016 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition ...
CAMBRIDGE, Mass., Sept. 05, 2017 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader ...
